Immunoassay News and Research

RSS

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

A new study proposes a multi-boost vaccine strategy with a longer duration between the second and third dose, as that would be beneficial in acquiring immunity against severely mutated SARS-CoV-2 variants.

22 Dec 2021

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

A new study assessed nAb activities against five strains of SARS-CoV-2 in paired maternal and infant cord blood samples.

15 Dec 2021

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

Researchers compared the binding of the new SARS-CoV-2 VOC Omicron’s RBD and ACE2 receptor with the original Wuhan SARS-CoV-2 strain and other VOCs such as Beta and Delta.

15 Dec 2021

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

In a new study, researchers compared the serum levels of bioactive lipids in a cohort of 50 in-patients who had confirmed symptomatic SARS-CoV-2 infection with that of a control group.

14 Dec 2021

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

New study findings showed evidence of SARS-CoV-2 dissemination in Ireland prior to the identification of the first official COVID-19 case.

8 Dec 2021

Homologous mRNA and heterologous vaccines elicit high immune responses

New study findings show that homologous mRNA or heterologous vaccination induces the highest immune responses due to high RBD- and S1-specific antibodies.

7 Dec 2021

Equipment-free handheld microfluidic injection provides visible readout of SARS-CoV-2 detection

In this paper, a group of researchers from Harvard Medical School, McGill University, and Tianjin University describes an on-chip diagnostic technology for the direct detection of SARS-CoV-2 N protein in nasal samples that combines the advantages of hydrodynamic microfluidic filtration and sandwich immunoassay.

5 Dec 2021

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

In new studies, researchers concluded that licorice triterpenoids could be candidates for anti-SARS-CoV-2 drug developments.

2 Dec 2021

Paper-based innovations for COVID-19 diagnosis

A review discusses paper-based devices and platforms targeting SARS-CoV-2 for low-cost PoC diagnosis and serological antibody testing.

22 Nov 2021

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Turkish researchers discuss their rapid electrochemical biosensing platform to detect the SARS-CoV-2 spike antibody.

22 Nov 2021

Clinically applicable strategy for early identification of IFN-AAB-positive COVID-19 patients

Researchers from the Humboldt-Universität zu Berlin have been investigating the presence of these antibodies in hospitalized COVID-19 patients to examine the potential of using them as a biomarker for severe disease.

17 Nov 2021

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Scientists from Northwestern University, USA, have recently developed a high-throughput, automated screening platform to rapidly identify anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.

8 Nov 2021

Immunoassay News and Research

Extended interval between second and third vaccination beneficial against SARS-CoV-2 Omicron variant

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

Study shows SARS-CoV-2 transmission in Ireland before first official COVID-19 report

Homologous mRNA and heterologous vaccines elicit high immune responses

Equipment-free handheld microfluidic injection provides visible readout of SARS-CoV-2 detection

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Paper-based innovations for COVID-19 diagnosis

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Clinically applicable strategy for early identification of IFN-AAB-positive COVID-19 patients

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

Trends in SARS-CoV-2 seroprevalence in Massachusetts

The Connection between High-sensitivity Troponin and Heart Attacks

NIH RADx initiative announces $77.7 million to develop new rapid COVID-19 diagnostic tests

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

Study shows lower SARS-CoV-2 infection rates in smokers

Quantification of antibody titers against SARS-CoV-2 variants elicited by BNT162b2 vaccine

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News